RecallDepth
Class II Ongoing

LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 30-count (NDC: 13668-115-30), b) 90-count (NDC: 13668-115-90), c) 1000-count (NDC: 13668-115-10) per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

This recall is currently active, issued February 27, 2019. It was issued by Torrent Pharma Inc..

Company
Torrent Pharma Inc.
Recall Initiated
December 20, 2018
Posted
February 27, 2019
Recall Number
D-0501-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
83,016 bottles
Firm Location
Kalamazoo, MI, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Distribution

Nationwide USA and Puerto Rico

Lot / Code Info

Count, lots, expiry: [30-count bottle] Lot BO31C016, exp 04/2019; [90-count bottle] Lot BO31C016, exp 04/2019; [1000-count bottle] Lots 4DK3C004, 4DK3C005, exp 04/2019; Lots 4DU3C040, exp 10/2019; Lots 4DU3E049, 4DU3E050, exp 05/2021

More recalls by Torrent Pharma Inc.

View all recalls by this company →

Other recent Class II Drug recalls